Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine

Journal of Medical Virology

Volumn 50, Issue 2, 1996, Pages 105-111

  Mbawuike, Innocent N ^a   Piedra, Pedro A ^a   Cate, Thomas R ^a   Couch, Robert B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cell mediated immunity; Children; Viral vaccines

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; RECOMBINANT VACCINE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; INFANT; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES, VIRAL; CELLS, CULTURED; HUMANS; IMMUNIZATION; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

INFLUENZA A VIRUS; INFLUENZA VIRUS; TIPULA IRIDESCENT VIRUS;

EID: 0029862116     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199610)50:2<105::AID-JMV1>3.0.CO;2-E     Document Type: Article

References (25)

1. Ada GL, Jones PD (1986): The immune response to influenza infection. Current Topics in Immunology and Microbiology 128:1-54.
2. Ada GL, Leung KN, Ertl H (1981): An analysis of T-cell generation and function in mice exposed to influenza A or Sendai viruses. Immunological Reviews 58:5-24.
3. Anderson EL, Belshe RB, Burke B, Bartram J, Maassab HF (1989): Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants. Journal of Clinical Microbiology 27:909-914.
4. Dolin R, Murphy BR, Caplan EA (1978): Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans. Infection and Immunity 19:867-874.
5. Ennis FA, Yi-Hua Q, Riley D, Rook AH, Schild GC, Pratt R, Potter CW (1981): HLA-restricted virus-specific cytotoxic T lymphocyte responses to live and inactivated influenza vaccines. Lancet 2:887-891
6. Ennis FA, Yi-Hua Q, Schild GC (1982): Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines. Journal of General Virology 58:273-281.
7. Feldman S, Wright PF, Webster RG, Roberson PK, Mahoney J, Thompson J, Doolittle M, Lott L, Johnson P, Christoph RC (1985): Use of influenza A virus vaccines in seronegative children: Live cold-adapted versus inactivated whole virus. Journal of Infectious Disease 152:1212-1218.
8. Frank AL, Couch RB, Griffis CA, Baxter BD (1979): Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. Journal of Clinical Microbiology 10:32-36.
9. Glezen WP, Frank AL, Taker LH, Tristan MP, Vallbona C, Paredes A, Allison JE (1983): Influenza in childhood. Pediatric Research 17:1029-1032.
10. Glezen WP, Six HR, Perrotta DM, Decker M, Joseph S (1984): Epidemics and their causative viruses - Community experience In Stuart-Harris C, Potter CW (eds): "The Molecular Virology and Epidemiology of Influenza." London: Academic Press, p 17.
11. Griffiths PD, Berney SI, Argent S, Heath RB (1982): Antibody against viruses in maternal and cord sera: Specific antibody is concentrated on the fetal side of the circulation. Journal of Hygiene 89:303-310.
12. Isaacs D, Bangham CRM, McMichael AJ (1987): Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 2:769-771.
13. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF (1986): Immunity to influenza A virus infection in young children: A comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. Journal of Infectious Disease 154:121-127.
14. Lazar A, Wright PR (1980): Cell-mediated immune response of human lymphocyte to influenza A/USSR (H1N1) virus infection. Infection and Immunity 27:867-871.
15. Mbawuike IN, Wyde PR, Anderson PM (1990): Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes. Vaccine 8:347-352.
16. Mbawuike IN, Lange AR, Couch RB (1993): Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunology 6:55-64.
17. McMichael AJ, Askonas B (1978): Influenza virus cytotoxic T cells in man: Induction and properties of the cytotoxic cell. European Journal of Immunology 8:705-711.
18. McMichael AJ, Gotch FM, Cullen P, Askonas B, Webster RG (1981): The human cytotoxic T-cell response to influenza A vaccination. Clinical and Experimental Immunology 43:276-284.
19. McMichael AJ, Gotch FM, Hildreth JEK (1982): Lysis of allogeneic human lymphocytes by non specifically activated T-like cells. European Journal of Immunology 12:1002-1005.
20. McMichael AJ, Gotch FM, Noble GR, Beare PAS (1983): Cytotoxic T-cell immunity to influenza. New England Journal of Medicine 309:13-17.
21. Piedra PA, Glezen WP, Mbawuike I, Gruber WC, Baxter BD, Boland FJ, Byrd RW, Fan LL, Lewis JK, Rhodes LJ, Whitney SE, Taber LH (1993): Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent virus (TI) vaccines in infants and young children. Vaccine 11:718-724.
22. Ruben F, Bachmayer H (1978): Lymphocyte responses to hemagglutinin and neuraminidase subunits of influenza virus. Journal of Clinical Microbiology 7:558-761.
23. Webster RG, Askonas BA (1980): Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. European Journal of Immunology 10:396-401.
24. Wright PF, Thompson J, Karzon DT (1977): Influenza A infections in young children. Primary natural infection and protective efficacy of live vaccine-induced or naturally acquired immunity. New England Journal of Medicine 296:829-834.
25. Zahradnik JM, Frank AL, Taber LH (1983): Serum neutralizing antibody and lymphocyte transformation after influenza B virus infections. Journal of Clinical Microbiology 18:1266-1268.